CD44 and cancer: Subsequently, we also observed that CD34-overexpressing PKP+ cancer cells increased p-AKT, p-STAT3, and CD44 cancer stemness protein expression, but reduced p-AMPK protein levels according to Western blot analysis (Figure 5I).